Catch up with our latest volumes and outcomes data
Below we share recent volumes and clinical outcomes from a sampling of areas in Cleveland Clinic’s Miller Family Heart, Vascular & Thoracic Institute: thoracic surgery, lung transplantation and two unique populations — patients with hypertrophic obstructive cardiomyopathy and patients with pericarditis.
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
The following data and ratings are from the Society of Thoracic Surgeons (STS) General Thoracic Surgery Database (3-year period ending December 2022):
Image content: This image is available to view online.
View image online (https://assets.clevelandclinic.org/transform/5d8a787e-6cb8-4cc7-b09b-634a230a3dd1/23-HVI-4148016-CQD-charts1_png)
Image content: This image is available to view online.
View image online (https://assets.clevelandclinic.org/transform/60ed1d11-6b19-4774-a184-af358109038a/23-HVI-4148016-CQD-charts2_png)
Image content: This image is available to view online.
View image online (https://assets.clevelandclinic.org/transform/6da5e679-a665-4188-8f3b-b5a6b694b7a3/23-HVI-4148016-CQD-charts3_png)
Of 103 rated participants in this STS category, Cleveland Clinic was 1 of 15 that achieved a 3-star (highest) rating.
Image content: This image is available to view online.
View image online (https://assets.clevelandclinic.org/transform/bffe992a-c37a-45ee-8e9b-390a0888ab32/23-HVI-4148016-CQD-charts4_png)
Cleveland Clinic’s Heart, Vascular & Thoracic Institute has a long-established tradition of reporting volume and outcomes data across its various subspecialty areas. For more information like the data reported above, visit clevelandclinic.org/hvtioutcomes and clevelandclinic.org/e15.
Advertisement
Advertisement
Our latest performance data in these areas plus HOCM and pericarditis
Our latest volumes and outcomes data in these areas plus HOCM and pericarditis
CD36 loss-of-function variant accounts for large portion of risk in this population
Milestone minimally invasive surgeries reduce pain and recovery time
End-of-treatment VALOR-HCM analyses reassure on use in women, suggest disease-modifying potential
Ideation session generates solutions to medication administration errors
Caregivers spearhead changes that improve patient care, shape hospital culture
Potentially cost-effective addition to standard GERD management in post-transplant patients